A. M. Zvonok

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Mohab Ibrahim, Hongfeng Deng, A. M. Zvonok et al. · Proceedings of the National Academy of Sciences · 2003 · 486 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

Andrea G. Hohmann, Jesse N. Farthing, A. M. Zvonok et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 121 citations

Medicine, Pharmacology, Neuropharmacology +16

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

Elizabeth J. Rahn, A. M. Zvonok, Ganesh A. Thakur et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Activation of Cannabinoid CB₂Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation

Andrea G. Nackley, A. M. Zvonok, Alexandros Makriyannis et al. · Journal of Neurophysiology · 2004 · 111 citations

Medicine, Neuroscience, Pharmacology +17

Activation of peripheral cannabinoid CB₁and CB₂receptors suppresses the maintenance of inflammatory nociception: a comparative analysis

T. Gutierrez, Jesse N. Farthing, A. M. Zvonok et al. · British Journal of Pharmacology · 2006 · 105 citations · Full text

Medicine, Pharmacology, Hypersensitivity +16